Indigenous scientist Jessica Schaub will explore jellyfish blooms in Japan, France, Argentina and Australia. (Vancouver Aquarium)   From some of the largest jellyfish in the world in Japan to the tiny venomous Irukandji in Australia, UBC doctoral student Jessica Schaub is about to set off on an international tour of jellyfish. A doctoral student in the department of earth, ocean…
Read More
Do you know your A’s, C’s, G’s and T’s? They are the four types of bases in a DNA molecule which consists of two strands wound around each other to form an organism’s complete set of DNA, called its genome.   DNA carries the instructions for making specific proteins or sets of proteins. There are about 20,000 genes in the…
Read More
In a newly published study, researchers from SFU’s Functional and Anatomical Imaging & Shape Analysis Lab (FAISAL) identified distinct properties of brain MRIs and genetics that impact the prediction of Dementia of Alzheimer’s Type, or DAT, for patients at various stages of the disease, then developed a biomarker that can help predict future conversion to DAT. “Our findings reveal that while…
Read More
Researchers at UBC’s School of Biomedical Engineering have discovered that an existing cancer drug could have potential as a treatment for muscular dystrophy. The researchers found that the drug — known as a colony-stimulating factor 1 receptor (CSF1R) inhibitor — helped slow the progress of Duchenne muscular dystrophy in mice by increasing the resiliency of muscle fibres.
Read More

Announcing the SCI Accelerate 2022 Cohort

We are excited to announce the 2022 cohort of Praxis SCI Accelerate, a 12 week in residence accelerator program focused on advancing the commercialization of technology to transform the lives of people with spinal cord injury (SCI). Our cohort, encompassing companies across the key SCI focus areas for Praxis represent a variety of backgrounds and have already demonstrated significant traction…
Read More
STEMCELL Technologies, Canada’s largest biotechnology company, announced today that it has received ISO 14001:2015 certification of its Environmental Management System at its Canadian operations in Vancouver, BC. STEMCELL’s now-certified Environmental Management System will enable the company to monitor, measure, analyze, and evaluate its environmental performance.
Read More
Congratulations to Andrew Weng for receiving the Leukemia and Lymphoma Society of Canada (LLSC) Blood Cancer Research Jump Start Grant for this research entitled, “Functional modeling of MYC translocation in follicular lymphoma.” The LLSC has put together this award recognizing that the COVID-19 pandemic has affected researchers’ capacity to conduct their regular research and training activities. The LLSC’s Jump Start Grant is…
Read More
More than a dozen people with cancer who had exhausted all treatment options are alive and cancer-free today thanks to a pioneering Canadian clinical trial of a highly personalized kind of immunotherapy. The results, presented at the 2022 Cell Therapy Transplant Canada Conference, could open the door to a new era of made-in-Canada immunotherapies for cancer. Patients in the trial had…
Read More
Global leader in non-viral delivery of genomic medicines, Precision NanoSystems (PNI), entered into a strategic collaboration agreement with Aurora Vaccines to accelerate the development and manufacture of its Hepatitis C vaccine candidate. PNI will share its expertise in the development of the RNA payload platform and its proprietary lipid nanoparticle (LNP) platforms to help bring Aurora’s RNA-LNP vaccine candidate for…
Read More
On April 6, 2022, the 11th annual Norman Bethune Symposium returned to UBC Robson Square, in its first-ever hybrid format since the beginning of the COVID-19 pandemic. The symposium honours Dr. Norman Bethune, a pioneer in the field of blood transfusion during the Spanish Civil War. This year, the hard-working team at the Centre for Blood Research (CBR) used two different platforms to allow in-person…
Read More